Lack of Cutaneous B Cells Differentiates Lupus-Like Skin Disease in MRL/lpr Mice from Human Discoid Lupus

被引：0
|
作者：
Yon, Joshuah [1 ]
Curran, Timothy [2 ]
Richardson, Christopher T. [3 ]
机构：
[1] Univ Rochester, Rochester, NY USA
[2] Univ Rochester, Med Ctr, Dept Dermatol, Rochester, NY USA
[3] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 06期
关键词：
B cell; Cutaneous lupus; Discoid lupus; Lupus; MRL/lpr;
D O I：
10.1016/j.jid.2023.11.012
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1392 / 1394.e1
页数：4
相关论文
共 50 条
  • [31] Topical Endocannabinoid Administration Protects MRL-Lpr/Lpr Mice from Cutaneous Lupus Erythematosus
    Chalmers, Samantha
    Garcia, Sayra
    Draganski, Andrew
    Doerner, Jessica
    Friedman, Adam
    Friedman, Joel
    Putterman, Chaim
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] ANTI-RNA POLYMERASE-I ANTIBODIES IN SERA OF MRL LPR/LPR AND MRL +/+ AUTOIMMUNE MICE - CORRELATION OF ANTIBODY-PRODUCTION WITH DELAYED ONSET OF LUPUS-LIKE DISEASE IN MRL +/+ MICE
    STETLER, DA
    SIPES, DE
    JACOB, ST
    JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06): : 1760 - 1770
  • [33] RETRACTION: Tlr5 deficiency exacerbates lupus-like disease in the MRL/lpr mouse model
    Alajoleen, R. M.
    Oakland, D. N.
    Estaleen, R.
    Shakeri, A.
    Lu, R.
    Appiah, M.
    Sun, S.
    Neumann, J.
    Kawauchi, S.
    Cecere, T. E.
    McMillan, R. P.
    Reilly, C. M.
    Luo, X. M.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [34] Masp-1/3 Deficient MRL/Lpr Mice Lack The Alternative Complement Pathway Activation and Are Protected From Development Of Lupus-Like Glomerulonephritis
    Machida, Takeshi
    Sakamoto, Natsumi
    Fujita, Teizo
    Takahashi, Minoru
    Sekine, Hideharu
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1241 - S1241
  • [35] BENEFICIAL EFFECT OF CAPTOPRIL ON SYSTEMIC LUPUS ERYTHEMATOSUS-LIKE DISEASE IN MRL LPR/LPR MICE
    HERLITZ, H
    TARKOWSKI, A
    SVALANDER, C
    VOLKMANN, R
    WESTBERG, G
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1988, 85 (03): : 272 - 277
  • [36] ES-62 prevents development of lupus-like pathology in the MRL/Lpr mouse
    Rodgers, David
    McGrath, Mairi
    Pineda, Miguel
    Al-Riyami, Lamyaa
    Harnett, William
    Harnett, Margaret
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [37] LPR T-CELLS VACCINATE AGAINST LUPUS IN MRL/LPR MICE
    DEALBORAN, IM
    GUTIERREZ, JC
    GONZALO, JA
    ANDREU, JL
    MARCOS, MAR
    KROEMER, G
    MARTINEZA, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (04) : 1089 - 1093
  • [38] Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL/lpr mice: comment on the article by Zheng et al
    Huang, An-Fang
    Xu, Wang-Dong
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (11) : 2064 - 2065
  • [39] EFFECTS OF ORAL ASPIRIN AND OXAPROZIN ON THE DEVELOPMENT OF LUPUS-LIKE DISEASE IN MRL/1 MICE
    CARLSON, RP
    GILMAN, SC
    HODGE, TG
    ONEILLDAVIS, L
    BLAZEK, EM
    LEWIS, AJ
    JOURNAL OF IMMUNOPHARMACOLOGY, 1984, 6 (1-2): : 69 - 78
  • [40] Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice
    Kulkarni, Onkar P.
    Ryu, Mi
    Kantner, Claudia
    Sardy, Miklos
    Naylor, Dean
    Lambert, Daniel
    Brown, Richard
    Anders, Hans-Joachim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1358 - 1367
12345